12 Sept 2022 , 02:51 PM
Zydus was among the first ANDA applicants to file a substantially complete ANDA with a paragraph IV certification for Cariprazine Capsules, 1.5 mg, 3 mg, 4.5 mg, and 6 mg, making it eligible for 180 days of shared generic drug exclusivity for Cariprazine Capsules, 1.5 mg, 3 mg, 4.5 mg, and 6 mg.
Cariprazine is an atypical antipsychotic that is used to treat schizophrenia as well as acute manic or mixed episodes associated with Bipolar I disorder. The medicine would be manufactured at the group's formulation manufacturing plant in Ahmedabad Special Economic Zone, India.
According to IQVIA MAT July 2022, Cariprazine Capsules had yearly sales of USD 2.39 billion in the United States.
Since the beginning of the filing procedure in FY 2003-04, the group has so far received 322 approvals and has submitted over 428 ANDAs.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.